Fig. 2: Adjuvant endocrine therapy treatment patterns across year of diagnosis, stratified by cancer stage. | npj Breast Cancer

Fig. 2: Adjuvant endocrine therapy treatment patterns across year of diagnosis, stratified by cancer stage.

From: Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer

Fig. 2

A Temporal trends in initial type of adjuvant endocrine therapy received (AI vs. SERM). B Temporal trends in use of ovarian function suppression. AI, aromatase inhibitor; SERM, selective estrogen receptor modulator; OFS, ovarian function suppression; N, total number of patients diagnosed within time interval.

Back to article page